| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.3 | 0.07 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |